Skip to main content
logo
Hofseth BioCare ASA (OSL:HBC)
Norway flag Norway · Delayed Price · Currency is NOK
1.100
+0.015 (1.38%)
Nov 4, 2026, 12:02 PM CET

Hofseth BioCare ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
63.0948.7971.1454.867.7760.7264.9367.6172.1952.145.8949.6250.7744.5333.8529.7925.2830.2215.4513.66
Other Revenue
2.60.691.010.090.670.14-0.040.278.220.261.540.2625.660.24-0.240.440.560.5710.63-
Revenue
65.6949.4872.1554.8968.4460.8664.8967.8980.4152.3647.4349.8976.4344.7733.6130.2225.8330.7826.0813.66
Revenue Growth (YoY)
-4.02%-18.71%11.20%-19.15%-14.88%16.24%36.82%36.08%5.21%16.95%41.11%65.06%195.85%45.43%28.87%121.29%-16.78%82.85%13.13%80.22%
Cost of Revenue
34.6329.3169.135.3835.7537.4765.8349.0147.6227.3563.7432.8627.0841.3138.1824.4817.7422.0933.4813.62
Gross Profit
31.0620.173.0519.5132.723.4-0.9518.8732.7925.01-16.3217.0249.353.46-4.575.748.098.7-7.40.04
Selling, General & Admin
16.8722.6246.0621.6314.3820.2242.619.3112.1217.3435.4715.5110.8814.437.3614.639.2614.7927.6911.96
Other Operating Expenses
16.8520.72-16.4418.9923.6920.08-17.4620.5822.6523.9-1217.6820.1417.56-13.6616.5217.1720.11-8.4917.33
Operating Expenses
43.9453.7840.450.1147.5549.8635.8249.4244.3651.2232.9642.1940.9739.9230.4938.8634.8842.1626.636.79
Operating Income
-12.88-33.61-37.35-30.6-14.86-26.47-36.76-30.54-11.57-26.21-49.28-25.178.38-36.46-35.06-33.11-26.79-33.47-34.01-36.75
Interest Expense
-7.66-7.23-6.83-5.93-5.96-4.11-4.63-4.14-3.64-3.28-0.43-2.24-2.58-2.3-2.84-2.14-2.88-2.09-4.34-1.24
Interest & Investment Income
0.110.240.940.480.570.010.770.010.0100.5501.78-0.560.090-0.6-
Earnings From Equity Investments
-2.39-1-3.387.09-0.77-0.78-3.83-1.01-1.83-0.81-2.495.03---0.2---0.03-
Currency Exchange Gain (Loss)
-0.395.03-1.610.65-3.981.270.730.68-0.541.29-0.25-0.34-0.030.92-0.540.11.29-0.110.520.2
Other Non Operating Income (Expenses)
--0.05----000--00-1.79-0.050-0--0-
EBT Excluding Unusual Items
-23.21-36.57-48.18-28.31-25-30.09-43.72-35.01-17.56-29.01-51.9-22.725.76-37.84-38.04-35.07-28.38-35.67-37.19-37.79
Merger & Restructuring Charges
------3.03--------------
Asset Writedown
---0.09------------0.19-----
Pretax Income
-23.21-36.57-48.28-28.31-25-33.12-43.72-35.01-17.56-29.01-51.9-22.725.76-37.84-38.22-35.07-28.38-35.67-37.19-37.79
Income Tax Expense
0.18---0.18---------------
Earnings From Continuing Operations
-23.4-36.57-48.28-28.31-25.18-33.12-43.72-35.01-17.56-29.01-51.9-22.725.76-37.84-38.22-35.07-28.38-35.67-37.19-37.79
Minority Interest in Earnings
-0---00-----0-0---0-
Net Income
-23.4-36.57-48.28-28.31-25.18-33.12-43.72-35.01-17.56-29.01-51.9-22.725.76-37.84-38.22-35.07-28.38-35.67-37.19-37.79
Net Income to Common
-23.4-36.57-48.28-28.31-25.18-33.12-43.72-35.01-17.56-29.01-51.9-22.725.76-37.84-38.22-35.07-28.38-35.67-37.19-37.79
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
411411411411411411411411411410395395395395395388358358358358
Shares Outstanding (Diluted)
426426411412412412412411412412396396396396396393363363358358
Shares Change (YoY)
3.40%3.40%-0.24%0.24%-0.04%0.13%3.99%3.74%4.04%3.86%0.04%0.75%9.05%9.05%10.69%9.92%-1.54%1.30%6.88%
EPS (Basic)
-0.06-0.09-0.12-0.07-0.06-0.08-0.11-0.09-0.04-0.07-0.13-0.060.01-0.10-0.10-0.09-0.08-0.10-0.10-0.11
EPS (Diluted)
-0.06-0.09-0.12-0.07-0.06-0.08-0.11-0.09-0.04-0.07-0.13-0.060.01-0.10-0.10-0.09-0.08-0.10-0.10-0.11
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-5.36-24.615.58-3.06-35.25-15.3920.13-13.330.47-21.12-12.736.981.82-1.5147.72-40.37-44.14-12.4-21.31-21.43
Free Cash Flow Per Share
-0.01-0.060.01-0.01-0.09-0.040.05-0.030.00-0.05-0.030.020.01-0.000.12-0.10-0.12-0.03-0.06-0.06
Gross Margin
47.28%40.77%4.23%35.54%47.77%38.44%-1.46%27.80%40.78%47.77%-34.41%34.12%64.56%7.73%-13.61%19.01%31.33%28.25%-28.38%0.30%
Operating Margin
-19.60%-67.93%-51.76%-55.76%-21.71%-43.49%-56.66%-44.99%-14.39%-50.06%-103.91%-50.45%10.96%-81.44%-104.33%-109.56%-103.69%-108.72%-130.39%-269.12%
Profit Margin
-35.61%-73.91%-66.91%-51.58%-36.79%-54.41%-67.38%-51.57%-21.84%-55.40%-109.43%-45.53%7.54%-84.52%-113.73%-116.03%-109.87%-115.86%-142.60%-276.72%
Free Cash Flow Margin
-8.15%-49.74%7.74%-5.57%-51.50%-25.29%31.02%-19.63%0.59%-40.33%-26.83%13.99%2.38%-3.36%141.98%-133.57%-170.84%-40.29%-81.69%-156.89%
EBITDA
-8.76-27.01-33.63-27.12-5.37-16.91-32.05-21.02-1.98-16.23-46.77-16.1618.33-28.5-32.72-25.4-18.33-26.21-29.08-29.25
EBITDA Margin
-13.33%-54.59%-46.61%-49.41%-7.85%-27.79%-49.40%-30.96%-2.46%-30.99%-98.62%-32.40%23.99%-63.66%-97.36%-84.05%-70.95%-85.13%-111.52%-214.14%
D&A For EBITDA
4.126.63.723.499.489.564.719.539.599.982.519.019.967.962.347.718.467.264.927.51
EBIT
-12.88-33.61-37.35-30.6-14.86-26.47-36.76-30.54-11.57-26.21-49.28-25.178.38-36.46-35.06-33.11-26.79-33.47-34.01-36.75
EBIT Margin
-19.60%-67.93%-51.76%-55.76%-21.71%-43.49%-56.66%-44.99%-14.39%-50.06%-103.91%-50.45%10.96%-81.44%-104.33%-109.56%-103.69%-108.72%-130.39%-269.12%
Revenue as Reported
65.6949.4872.1554.8968.4460.8664.8967.8980.4152.3647.4349.8976.4344.7733.6130.2225.8330.7826.0813.66